Home › Down Syndrome › Michigan › Ann Arbor
Down Syndrome clinical trials in Ann Arbor, MI
5 studies for Down Syndrome are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Recruiting
- University of Michigan, Ann Arbor
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- C S Mott Children's Hospital, Ann Arbor
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
RecruitingObservational study
- C S Mott Children's Hospital, Ann Arbor
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
Recruiting
- The University of Michigan, Ann Arbor
Down Syndrome Obstructive Sleep Apnea
RecruitingPhase 2
- University of Michigan, Ann Arbor Hospital, Ann Arbor
About Down Syndrome
About 1 in 700 babies are born with the birth defect known as Down Syndrome. Learn about the different Down Syndrome types and related health issues.
More about Down Syndrome on MedlinePlus
Down Syndrome trials in other cities
- Aurora, CO7 studies
- Durham, NC6 studies
- Houston, TX6 studies
- Phoenix, AZ6 studies
- Nashville, TN5 studies
- Cincinnati, OH5 studies
- Cleveland, OH5 studies
- Kansas City, KS5 studies
- Philadelphia, PA5 studies
- Orlando, FL5 studies
- Birmingham, AL4 studies
- San Diego, CA4 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Breast Cancer26 studies
- Cancer (all types)26 studies
- Non-Small Cell Lung Cancer25 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.